Landscape of Transcriptional Deregulations in the Preeclamptic Placenta

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Vaiman, Daniel ^a   Calicchio, Rosamaria ^a   Miralles, Francisco ^a  

^a INSTITUT COCHIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING ENHANCER BINDING PROTEIN 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID ZINC FINGER 1 PROTEIN; MYOCYTE ENHANCER FACTOR 2A; NUCLEAR TRANSCRIPTION FACTOR Y ALPHA; RAS RESPONSIVE ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PLACENTA DISORDER; PREECLAMPSIA; PREECLAMPTIC PLACENTA; PROMOTER REGION; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION;

BINDING SITES; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR SEQUENCE ANNOTATION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN INTERACTION MAPS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84878970539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065498     Document Type: Article

References (108)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R, (2010) Pre-eclampsia. Lancet 376: 631-644.
2. Sibai BM, (2012) Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 206: 470-475.
3. James JL, Whitley GS, Cartwright JE, (2010) Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces. J Pathol 221: 363-378.
4. Wang A, Rana S, Karumanchi SA, (2009) Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) 24: 147-158.
5. Louwen F, Muschol-Steinmetz C, Reinhard J, Reitter A, Yuan J, (2012) A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget 3: 759-773.
6. Tapia A, Vilos C, Marin JC, Croxatto HB, Devoto L, (2011) Bioinformatic detection of E47, E2F1 and SREBP1 transcription factors as potential regulators of genes associated to acquisition of endometrial receptivity. Reprod Biol Endocrinol 9: 14.
7. Davidson EH (2006) The Regulatory Genome: Gene Regulatory Networks in Development and Evolution; Burlington M, editor. San Diego, USA: Academic Press.
8. Sitras V, Paulssen RH, Gronaas H, Leirvik J, Hanssen TA, et al. (2009) Differential placental gene expression in severe preeclampsia. Placenta 30: 424-433.
9. Meng T, Chen H, Sun M, Wang H, Zhao G, et al. (2012) Identification of differential gene expression profiles in placentas from preeclamptic pregnancies versus normal pregnancies by DNA microarrays. OMICS 16: 301-311.
10. Tsai S, Hardison NE, James AH, Motsinger-Reif AA, Bischoff SR, et al. (2011) Transcriptional profiling of human placentas from pregnancies complicated by preeclampsia reveals disregulation of sialic acid acetylesterase and immune signalling pathways. Placenta 32: 175-182.
11. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, et al. (2007) Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 28: 487-497.
12. Nishizawa H, Ota S, Suzuki M, Kato T, Sekiya T, et al. (2011) Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 9: 107.
13. Winn VD, Gormley M, Paquet AC, Kjaer-Sorensen K, Kramer A, et al. (2009) Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology 150: 452-462.
14. Suzuki Y, Yamashita R, Sugano S, Nakai K, (2004) DBTSS, DataBase of Transcriptional Start Sites: progress report 2004. Nucleic Acids Res 32: D78-81.
15. Piechota M, Korostynski M, Przewlocki R, (2010) Identification of cis-regulatory elements in the mammalian genome: the cREMaG database. PLoS One 5: e12465.
16. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA, (2005) Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21: 803-810.
17. Roider HG, Kanhere A, Manke T, Vingron M, (2007) Predicting transcription factor affinities to DNA from a biophysical model. Bioinformatics 23: 134-141.
18. Roider HG, Manke T, O'Keeffe S, Vingron M, Haas SA, (2009) PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics 25: 435-442.
19. Tonon L, Touzet H, Varre JS, (2010) TFM-Explorer: mining cis-regulatory regions in genomes. Nucleic Acids Res 38: W286-292.
20. Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, et al. (2005) TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 33: W393-396.
21. Aerts S, Thijs G, Coessens B, Staes M, Moreau Y, et al. (2003) Toucan: deciphering the cis-regulatory logic of coregulated genes. Nucleic Acids Res 31: 1753-1764.
22. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568.
23. Hayden MS, Ghosh S, (2012) NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26: 203-234.
24. Vaughan JE, Walsh SW, (2012) Activation of NF-kappaB in placentas of women with preeclampsia. Hypertens Pregnancy 31: 243-251.
25. Nakada E, Walley KR, Nakada T, Hu Y, von Dadelszen P, et al. (2009) Toll-like receptor-3 stimulation upregulates sFLT-1 production by trophoblast cells. Placenta 30: 774-779.
26. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, et al. (2001) Increased circulating lipid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J 15: 279-281.
27. Cooke CL, Davidge ST, (2002) Peroxynitrite increases iNOS through NF-kappaB and decreases prostacyclin synthase in endothelial cells. Am J Physiol Cell Physiol 282: C395-402.
28. Luppi P, Tse H, Lain KY, Markovic N, Piganelli JD, et al. (2006) Preeclampsia activates circulating immune cells with engagement of the NF-kappaB pathway. Am J Reprod Immunol 56: 135-144.
29. Haugen F, Drevon CA, (2007) Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 148: 5478-5486.
30. Dechend R, Viedt C, Muller DN, Ugele B, Brandes RP, et al. (2003) AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 107: 1632-1639.
31. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ, (2007) Nuclear factor-kappa B, p38, and stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170: 1511-1520.
32. Tan NY, Khachigian LM, (2009) Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29: 2483-2488.
33. Gascoin-Lachambre G, Buffat C, Rebourcet R, Chelbi ST, Rigourd V, et al. (2010) Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta 31: 151-157.
34. Kruger I, Vollmer M, Simmons DG, Elsasser HP, Philipsen S, et al. (2007) Sp1/Sp3 compound heterozygous mice are not viable: impaired erythropoiesis and severe placental defects. Dev Dyn 236: 2235-2244.
35. Mohibullah N, Donner A, Ippolito JA, Williams T, (1999) SELEX and missing phosphate contact analyses reveal flexibility within the AP-2[alpha] protein: DNA binding complex. Nucleic Acids Res 27: 2760-2769.
36. Ito T, Nomura S, Okada M, Katsumata Y, Kikkawa F, et al. (2002) Ap-2 and Ikaros regulate transcription of human placental leucine aminopeptidase/oxytocinase gene. Biochem Biophys Res Commun 290: 1048-1053.
37. Richardson BD, Langland RA, Bachurski CJ, Richards RG, Kessler CA, et al. (2000) Activator protein-2 regulates human placental lactogen gene expression. Mol Cell Endocrinol 160: 183-192.
38. Werling U, Schorle H, (2002) Transcription factor gene AP-2 gamma essential for early murine development. Mol Cell Biol 22: 3149-3156.
39. Johnson W, Jameson JL, (1999) AP-2 (activating protein 2) and Sp1 (selective promoter factor 1) regulatory elements play distinct roles in the control of basal activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human chorionic gonadotropin-beta promoter. Mol Endocrinol 13: 1963-1975.
40. Shi D, Kellems RE, (1998) Transcription factor AP-2gamma regulates murine adenosine deaminase gene expression during placental development. J Biol Chem 273: 27331-27338.
41. Kotani T, Iwase A, Ino K, Sumigama S, Yamamoto E, et al. (2009) Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line. Endocrinology 150: 4376-4385.
42. Depoix C, Tee MK, Taylor RN, (2011) Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway. Reprod Sci 18: 219-228.
43. Cheng HC, Shih HM, Chern Y, (2002) Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade. J Biol Chem 277: 33930-33942.
44. Maymo JL, Perez Perez A, Maskin B, Duenas JL, Calvo JC, et al. (2012) The Alternative Epac/cAMP pathway and the MAPK pathway mediate hCG induction of leptin in placental cells. PLoS One 7: e46216.
45. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E, (2000) Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev 14: 3191-3203.
46. Lunell NO, Nylund LE, Lewander R, Sarby B, (1982) Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera. Clin Exp Hypertens B 1: 105-117.
47. Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, et al. (2005) Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90: 4299-4308.
48. Combs CA, Katz MA, Kitzmiller JL, Brescia RJ, (1993) Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 169: 215-223.
49. Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA, (2001) Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 276: 12645-12653.
50. Minchenko A, Caro J, (2000) Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208: 53-62.
51. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C, (2002) Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem 277: 43799-43808.
52. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, et al. (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291: R1085-1093.
53. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, et al. (2002) Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 277: 42953-42957.
54. Gould PS, Gu M, Liao J, Ahmad S, Cudmore MJ, et al. (2010) Upregulation of urotensin II receptor in preeclampsia causes in vitro placental release of soluble vascular endothelial growth factor receptor 1 in hypoxia. Hypertension 56: 172-178.
55. Imperatore A, Rolfo A, Petraglia F, Challis JR, Caniggia I, (2010) Hypoxia and preeclampsia: increased expression of urocortin 2 and urocortin 3. Reprod Sci 17: 833-843.
56. Thiagalingam A, De Bustros A, Borges M, Jasti R, Compton D, et al. (1996) RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 16: 5335-5345.
57. Steinborn A, Varkonyi T, Scharf A, Bahlmann F, Klee A, et al. (2007) Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy. Am J Reprod Immunol 57: 277-286.
58. Zhu X, Han T, Yin G, Wang X, Yao Y, (2012) Expression of human leukocyte antigen-G during normal placentation and in preeclamptic pregnancies. Hypertens Pregnancy 31: 252-260.
59. Zhou X, Zhang GY, Wang J, Lu SL, Cao J, et al. (2012) A novel bridge between oxidative stress and immunity: the interaction between hydrogen peroxide and human leukocyte antigen G in placental trophoblasts during preeclampsia. Am J Obstet Gynecol 206: 447 e447-416.
60. Flajollet S, Poras I, Carosella ED, Moreau P, (2009) RREB-1 is a transcriptional repressor of HLA-G. J Immunol 183: 6948-6959.
61. Kimura C, Watanabe K, Iwasaki A, Mori T, Matsushita H, et al. (2012) The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med.
62. Crocker I (2007) Gabor Than Award Lecture 2006: pre-eclampsia and villous trophoblast turnover: perspectives and possibilities. Placenta 28 Suppl A: S4-13.
63. Bavisotto L, Kaushansky K, Lin N, Hromas R, (1991) Antisense oligonucleotides from the stage-specific myeloid zinc finger gene MZF-1 inhibit granulopoiesis in vitro. J Exp Med 174: 1097-1101.
64. Barcena A, Kapidzic M, Muench MO, Gormley M, Scott MA, et al. (2009) The human placenta is a hematopoietic organ during the embryonic and fetal periods of development. Dev Biol 327: 24-33.
65. Centlow M, Carninci P, Nemeth K, Mezey E, Brownstein M, et al. (2008) Placental expression profiling in preeclampsia: local overproduction of hemoglobin may drive pathological changes. Fertil Steril 90: 1834-1843.
66. Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, et al. (2012) Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 21: 1968-1978.
67. Auer J, Camoin L, Guillonneau F, Rigourd V, Chelbi ST, et al. (2010) Serum profile in preeclampsia and intra-uterine growth restriction revealed by iTRAQ technology. J Proteomics 73: 1004-1017.
68. Rajakumar A, Chu T, Handley DE, Bunce KD, Burke B, et al. (2011) Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta 32: 70-78.
69. O'Connor DJ, Lu X, (2000) Stress signals induce transcriptionally inactive E2F-1 independently of p53 and Rb. Oncogene 19: 2369-2376.
70. Lin SY, Black AR, Kostic D, Pajovic S, Hoover CN, et al. (1996) Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol Cell Biol 16: 1668-1675.
71. Pillai S, Kovacs M, Chellappan S, (2010) Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res 70: 4931-4940.
72. Higgins KJ, Abdelrahim M, Liu S, Yoon K, Safe S, (2006) Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins. Biochem Biophys Res Commun 345: 292-301.
73. Potthoff MJ, Olson EN, (2007) MEF2: a central regulator of diverse developmental programs. Development 134: 4131-4140.
74. Oishi Y, Manabe I, Imai Y, Hara K, Horikoshi M, et al. (2010) Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension. FASEB J 24: 1780-1788.
75. Dong JT, Chen C, (2009) Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases. Cell Mol Life Sci 66: 2691-2706.
76. van Thienen JV, Fledderus JO, Dekker RJ, Rohlena J, van Ijzendoorn GA, et al. (2006) Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res 72: 231-240.
77. Atkins GB, Jain MK, (2007) Role of Kruppel-like transcription factors in endothelial biology. Circ Res 100: 1686-1695.
78. Dolfini D, Gatta R, Mantovani R, (2012) NF-Y and the transcriptional activation of CCAAT promoters. Crit Rev Biochem Mol Biol 47: 29-49.
79. Nakshatri H, Bhat-Nakshatri P, Currie RA, (1996) Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Chem 271: 28784-28791.
80. Jin S, Fan F, Fan W, Zhao H, Tong T, et al. (2001) Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20: 2683-2690.
81. Xiong Y, Liebermann DA, Holtzman EJ, Jeronis S, Hoffman B, et al. (2013) Preeclampsia-associated stresses activate Gadd45a signaling and sFlt-1 in placental explants. J Cell Physiol 228: 362-370.
82. Sharp TV, Munoz F, Bourboulia D, Presneau N, Darai E, et al. (2004) LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci U S A 101: 16531-16536.
83. Foxler DE, Bridge KS, James V, Webb TM, Mee M, et al. (2012) The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol 14: 201-208.
84. Meinhardt G, Husslein P, Knofler M, (2005) Tissue-specific and ubiquitous basic helix-loop-helix transcription factors in human placental trophoblasts. Placenta 26: 527-539.
85. Bamberger AM, Makrigiannakis A, Schroder M, Bamberger CM, Relakis C, et al. (2004) Expression pattern of the CCAAT/enhancer-binding proteins C/EBP-alpha, C/EBP-beta and C/EBP-delta in the human placenta. Virchows Arch 444: 149-152.
86. He Y, Chen H, Quon MJ, Reitman M, (1995) The mouse obese gene. Genomic organization, promoter activity, and activation by CCAAT/enhancer-binding protein alpha. J Biol Chem 270: 28887-28891.
87. Basso K, Dalla-Favera R, (2010) BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis. Adv Immunol 105: 193-210.
88. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, et al. (1995) The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev 9: 3067-3082.
89. Webb CF, Bryant J, Popowski M, Allred L, Kim D, et al. (2011) The ARID family transcription factor bright is required for both hematopoietic stem cell and B lineage development. Mol Cell Biol 31: 1041-1053.
90. Fritah A, Christian M, Parker MG, (2010) The metabolic coregulator RIP140: an update. Am J Physiol Endocrinol Metab 299: E335-340.
91. Hitchens MR, Robbins PD, (2003) The role of the transcription factor DP in apoptosis. Apoptosis 8: 461-468.
92. Huang J, Teng L, Li L, Liu T, Chen D, et al. (2004) ZNF216 Is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation. J Biol Chem 279: 16847-16853.
93. Fujimoto K, Shen M, Noshiro M, Matsubara K, Shingu S, et al. (2001) Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun 280: 164-171.
94. Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, et al. (2012) SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature 487: 380-384.
95. Zhang Y, Dufau ML, (2004) Gene silencing by nuclear orphan receptors. Vitam Horm 68: 1-48.
96. Zhang Y, Dufau ML, (2000) Nuclear orphan receptors regulate transcription of the gene for the human luteinizing hormone receptor. J Biol Chem 275: 2763-2770.
97. van Dijk M, Oudejans CB, (2011) STOX1: Key Player in Trophoblast Dysfunction Underlying Early Onset Preeclampsia with Growth Retardation. J Pregnancy 2011: 521826.
98. Rigourd V, Chauvet C, Chelbi ST, Rebourcet R, Mondon F, et al. (2008) STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS One 3: e3905.
99. Doridot L, Passet B, Mehats C, Rigourd V, Barbaux S, et al. (2013) Preeclampsia-Like Symptoms Induced in Mice by Fetoplacental Expression of STOX1 Are Reversed by Aspirin Treatment. Hypertension 61: 662-668.
100. Eckner R, Arany Z, Ewen M, Sellers W, Livingston DM, (1994) The adenovirus E1A-associated 300-kD protein exhibits properties of a transcriptional coactivator and belongs to an evolutionarily conserved family. Cold Spring Harb Symp Quant Biol 59: 85-95.
101. Kasper LH, Lerach S, Wang J, Wu S, Jeevan T, et al. (2010) CBP/p300 double null cells reveal effect of coactivator level and diversity on CREB transactivation. EMBO J 29: 3660-3672.
102. Kwon HS, Kim DR, Yang EG, Park YK, Ahn HC, et al. (2012) Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1alpha-p300 interaction by a small molecule. Bioorg Med Chem Lett 22: 5249-5252.
103. Rubinstein JH, Taybi H, (1963) Broad thumbs and toes and facial abnormalities. A possible mental retardation syndrome. Am J Dis Child 105: 588-608.
104. Tsai AC, Dossett CJ, Walton CS, Cramer AE, Eng PA, et al. (2011) Exon deletions of the EP300 and CREBBP genes in two children with Rubinstein-Taybi syndrome detected by aCGH. Eur J Hum Genet 19: 43-49.
105. Vasarhelyi B, Cseh A, Kocsis I, Treszl A, Gyorffy B, et al. (2006) Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis. Mol Hum Reprod 12: 31-34.
106. Tsoi SC, Cale JM, Bird IM, Kay HH, (2003) cDNA microarray analysis of gene expression profiles in human placenta: up-regulation of the transcript encoding muscle subunit of glycogen phosphorylase in preeclampsia. J Soc Gynecol Investig 10: 496-502.
107. Reimer T, Koczan D, Gerber B, Richter D, Thiesen HJ, et al. (2002) Microarray analysis of differentially expressed genes in placental tissue of pre-eclampsia: up-regulation of obesity-related genes. Mol Hum Reprod 8: 674-680.
108. Pang ZJ, Xing FQ, (2004) DNA microarrays detect the expression of apoptosis-related genes in preeclamptic placentas. J Perinat Med 32: 25-30.